Home NDC 25021-325-84 Norepinephrine Bitartrate in Dextrose
Product NDC 25021-325
Requested package NDC 25021-325-84
11-digit product format 250210325
Labeler code 25021
Product ID 25021-325_31e01df0-0db5-49f8-9813-740020665889
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Norepinephrine Bitartrate
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Sagent Pharmaceuticals
Application ANDA219692
Marketing category ANDA
Marketing start 2026-11-15
Substance NOREPINEPHRINE BITARTRATE
Active strength 16 ug/mL
Pharmacologic classes Catecholamine [EPC], Catecholamines [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE NOREPINEPHRINE BITARTRATE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE NOREPINEPHRINE BITARTRATE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 c2088c7a36db…2026-09-14 22:38:34 2026-08 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219692-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219692-002 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2025-08-11 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 25021-325-84 25021032584 10 BAG in 1 CARTON (25021-325-84) / 250 mL in 1 BAG 10 bag 2026-11-15 No No Historical